Transferring the costs of expensive treatments

BMJ 1995; 310 doi: https://doi.org/10.1136/bmj.310.6990.1335 (Published 20 May 1995) Cite this as: BMJ 1995;310:1335

This article has a correction. Please see:

Guidelines may clarify responsibility for prescribing

  1. Matthew Young,
  2. Sonia Colwill,
  3. Jackie Spiby
  1. Research officer Pharmaceutical adviser Director of public health Bromley Health, Hayes, Kent BR2 7EH

    EDITOR,—Bromley Health has looked at ways of dealing with the transfer of expensive treatments from secondary to primary care.1 As a unified district health authority and family health services authority, it is ideally placed to deal with general practitioners' concerns, such as cost shifting, by making changes in the contracts with providers.

    Bromley Health's approach has been to draw up a list of drugs to be prescribed by hospital doctors and not by general practitioners. This advice is founded on …

    View Full Text

    Log in

    Log in through your institution


    * For online subscription